Onderneming Orion Biotech Opportunities Corp.
Aandelen
ORIA
KYG6780C1096
Holdingvennootschappen
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Zuie Chin Huang
FOU | Founder | 58 | 05-02-21 |
Chrystyna Stecyk
FOU | Founder | 61 | 05-02-21 |
Mark Kayal
DFI | Director of Finance/CFO | 39 | - |
Director/Board Member | 51 | - | |
Samuel Broder
BRD | Director/Board Member | 79 | - |
Corporate Officer/Principal | - | - | |
John Phelan
PRN | Corporate Officer/Principal | 60 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Zuie Chin Huang
FOU | Founder | 58 | 05-02-21 |
Samuel Broder
BRD | Director/Board Member | 79 | - |
James Collins
BRD | Director/Board Member | 58 | - |
Director/Board Member | 51 | - | |
Louisa Rodriguez
BRD | Director/Board Member | 64 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 5 000 000 | 0 | 0 | 74,00 % |
Aandeel B | 1 | 20 000 000 | 18 500 000 ( 92,50 %) | 0 |
Bedrijfsgegevens
Orion Biotech Opportunities Corp.
One Vanderbilt Avenue 26th floor
10017, New York
+
http://www.orionbiotechopportunities.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+107,89% | 4,54 mld. | |
+1,89% | 1,01 mld. | |
+2,00% | 980 mln. | |
-32,09% | 963 mln. | |
+41,91% | 872 mln. | |
+25,02% | 809 mln. | |
+1,63% | 664 mln. | |
+0,90% | 612 mln. | |
-.--% | 600 mln. |